Biftek Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$10K
- Investors
-
9
Biftek General Information
Description
Producer of novel culture medium supplement formulation intended to grow muscle stem cells. The company's supplement formulation helps in producing real meat without any genetic modifications or antibiotics, with clean meat technology that would not need animals and slaughterhouses, creating a clean meat revolution that can solve the growing food demand for all, enabling clients to cultivate affordable meat by decreasing related expenses dramatically.
Contact Information
Website
www.biftek.coCorporate Office
- 112 Capitol Trail
- Suite A526
- Newark, DE 19711
- United States
Corporate Office
- 112 Capitol Trail
- Suite A526
- Newark, DE 19711
- United States
Biftek Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Accelerator/Incubator | 25-Apr-2023 | $10K | Completed | Generating Revenue | ||
| 4. Early Stage VC | 11-Mar-2022 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series 1) | 01-Sep-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 30-Aug-2021 | $600K | $800K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 18-Aug-2020 | $200K | $200K | Completed | Stealth |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Biftek Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Biftek Patents
Biftek Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220098546-A1 | Microbiota-derived postbiotics: alternative supplement to fetal bovine serum for cultured meat | Pending | 28-Sep-2020 | ||
| WO-2023055412-A1 | Microbiota-derived postbiotics: alternative supplement to fetal bovine serum for cultured meat | Inactive | 28-Sep-2020 |
Biftek Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Biftek Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| European Bank for Reconstruction and Development | Growth/Expansion | |||
| Gedik Girisim Sermayesi Yatirim Ortakligi | Venture Capital | Minority | ||
| StartersHub | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Angel (individual) | Minority |
Biftek FAQs
-
When was Biftek founded?
Biftek was founded in 2020.
-
Where is Biftek headquartered?
Biftek is headquartered in Newark, DE.
-
What is the size of Biftek?
Biftek has 9 total employees.
-
What industry is Biftek in?
Biftek’s primary industry is Biotechnology.
-
Is Biftek a private or public company?
Biftek is a Private company.
-
What is Biftek’s current revenue?
The current revenue for Biftek is .
-
How much funding has Biftek raised over time?
Biftek has raised $1.41M.
-
Who are Biftek’s investors?
European Bank for Reconstruction and Development, Gedik Girisim Sermayesi Yatirim Ortakligi, StartersHub, , and are 5 of 9 investors who have invested in Biftek.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
